Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.97 USD | +0.50% | +9.31% | -31.04% |
Financials (USD)
Sales 2024 * | 360M | Sales 2025 * | 249M | Capitalization | 5.21B |
---|---|---|---|---|---|
Net income 2024 * | -513M | Net income 2025 * | -527M | EV / Sales 2024 * | 18.4 x |
Net Debt 2024 * | 1.42B | Net Debt 2025 * | 1.25B | EV / Sales 2025 * | 25.9 x |
P/E ratio 2024 * |
-9.54
x | P/E ratio 2025 * |
-9.48
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.72% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | +0.32% | ||
1 week | +11.86% | ||
Current month | +8.63% | ||
1 month | -0.96% | ||
3 months | -17.25% | ||
6 months | -3.47% | ||
Current year | -31.06% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 27.84 | +0.04% | 270 992 |
24-05-03 | 27.83 | +0.32% | 1,677,282 |
24-05-02 | 27.74 | +2.63% | 1,201,763 |
24-05-01 | 27.03 | +5.50% | 2,283,562 |
24-04-30 | 25.62 | +0.59% | 1,589,236 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.06% | 5.21B | |
-3.91% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- BBIO Stock